FDA grants accelerated approval to pemigatinib for cholangiocarcinoma
Oncology News burst
Oncology News burst
Immunology; Molecular biology; Cancer
Barry Stein first noticed blood in his stool when he was in his 30s and didn’ t think much of it. After further reflection, Stein…
Nature Communications – The role of sex differences in response to cancer therapy remains unclear but this could be improved by reporting sex comparisons of…
Immune checkpoint inhibitors have changed the treatment landscape for various malignancies; however, their benefit is limited to a subset of patients. The immune machinery includes…
Immune checkpoint inhibitors have changed the treatment landscape for various malignancies; however, their benefit is limited to a subset of patients. The immune machinery includes…
Cancer is traditionally diagnosed and treated on the basis of its organ of origin (e.g., lung or colon cancer). However, organ-of-origin diagnostics does not reveal…
We read with great interest the report by Watson et al 1 describing in detail a case of hyperprogression (HPD) after pembrolizumab in Epstein-Barr virus-associated…
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by…